COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2670: Articles 26691-26700  | Next

Rapid Epidemiological Analysis of Comorbidities andTreatments as risk factors for COVID-19 in Scotland(REACT-SCOT): a population-based case-control study
McKeigue, P. M., Weir, A., Bishop, J., McGurnaghan, S., Kennedy, S., McAllister, D., Robertson, C., Wood, R., Lone, N., Murray, J., Caparrotta, T., Smith-Palmer, A., Goldberg, D., McMenamin, J., Ramsay, C., Hutchinson, S., Colhoun, H. M.
10.1101/2020.05.28.20115394 — Posted: 2020-06-02 Discussion: Onsite
Estimated Sp02/Fio2 ratio to predict mortality in patients with suspected COVID-19 in the Emergency Department: a prospective cohort study
von Vopelius-Feldt, J., Watson, D., Swanson-Low, C., Cameron, J.
10.1101/2020.05.28.20116194 — Posted: 2020-06-02
Early CPAP reduced mortality in covid-19 patients. Audit results from Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust.
Ashish, A., Unsworth, A., Martindale, J., Sundar, R., Sedda, L., Farrier, M.
10.1101/2020.05.28.20116152 — Posted: 2020-06-02
The COVID-19 Critical Care Consortium observational study: Design and rationale of a prospective, international, multicenter, observational study
Li Bassi, G., Suen, J., Barnett, A. G., Corley, A., Millar, J. E., Fanning, J. P., Lye, I., Colombo, S., Wildi, K., Livingstone, S., Abbate, G., Hinton, S., Liquet, B., Shrapnel, S., Dalton, H. J., Fraser, J. F.
10.1101/2020.05.29.20115253 — Posted: 2020-06-02
G6PD variant distribution in sub-Saharan Africa and potential risks ofusing chloroquine/hydroxychloroquine based treatments forCOVID-19
da Rocha, J., Othman, H., Tiemessen, C. T., Botha, G., Ramsay, M., Masimirembwa, C., Adebamowo, C., Choudhury, A., Brandenburg, J.-T., Matshaba, M., Simo, G., Gamo, F.-J., Hazelhurst, S.
10.1101/2020.05.27.20114066 — Posted: 2020-06-02
Exhaled breath is a significant source of SARS-CoV-2 emission
Ma, J., Qi, X., Chen, H., Li, X., Zhan, Z., Wang, H., Sun, L., Zhang, L., Guo, J., Morawska, L., Grinshpun, S. A., Biswas, P., Flagan, R. C., Yao, M.
10.1101/2020.05.31.20115154 — Posted: 2020-06-02 Discussion: Onsite
Immunochromatographic assays for COVID-19 epidemiological screening: our experience
Bartolini, A., Scapaticci, M., Bioli, M., Lazzarotto, T., Re, M. C., Mancini, R.
10.1101/2020.05.28.20116046 — Posted: 2020-06-02
The Risk of Lifting COVID-19 Confinement in Mexico
Azanza Ricardo, C. L., Hernandez Vargas, E. A.
10.1101/2020.05.28.20115063 — Posted: 2020-06-02
How efficient are the lockdown measures taken for mitigating the Covid-19 epidemic?
Lasaulce, S., SATHEESKUMAR VARMA, V., Morarescu, C.
10.1101/2020.06.02.20120089 — Posted: 2020-06-02
Covid-19 testing strategies and lockdowns: the European closed curves, analysed by ``skew-normal'' distributions, the forecasts for the UK, Sweden, and the USA, and the ongoing outbreak in Brazil.
De Leo, S.
10.1101/2020.06.01.20119461 — Posted: 2020-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).